Related Experiment Videos

New dawn of cannabinoid pharmacology

¹Laboratory of Cell Biology, National Institute of Mental Health, Bethesda, MD 20892.

Trends in Pharmacological Sciences

|February 1, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.

Pharmacological reviews·2002

Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs.

European journal of pharmacology·1998

The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine.

Neuroscience letters·1997

Long-term synaptic transformation of hippocampal CA1 gamma-aminobutyric acid synapses and the effect of anandamide.

Proceedings of the National Academy of Sciences of the United States of America·1995

Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.

Molecular pharmacology·1995

Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes.

Proceedings of the National Academy of Sciences of the United States of America·1994

See all related articles